Skip to Content

EC 35 (Atelvia risedronate sodium delayed-release 35 mg)

Generic Name: risedronate

Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Atelvia risedronate sodium delayed-release 35 mg. It is supplied by Allergan, Inc..

Atelvia is used in the treatment of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Atelvia risedronate sodium delayed-release 35 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for EC 35

Atelvia

Generic Name:
risedronate
Imprint:
EC 35
Strength:
risedronate sodium delayed-release 35 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Allergan, Inc.
Inactive Ingredients:
edetate disodium
ferric oxide yellow
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polysorbate 80
microcrystalline cellulose
dimethicone
sodium starch glycolate type A potato
stearic acid
magnesium silicate
triethyl citrate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00591-3876 Watson Pharmaceuticals, Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide